The board of directors of healthcare company Pfizer Inc (NYSE:PFE) declared an unchanged dividend of USD0.36 per share on the company's common stock, it declared on Tuesday.
Holders of the common stock of record at the close of business as of 8 November 2019 will receive the dividend payment on 2 December 2019.
According to the company, the fourth-quarter 2019 cash dividend will be its 324th consecutive quarterly dividend.
Pfizer said it works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time through collaborations with health care providers, governments and local communities.
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Lilly declares Q2 2026 dividend
Collegium to acquire AZSTARYS from Corium Therapeutics
CVS Health announces quarterly dividend of USD0.665 per share
Convatec launches co-branded eakin freeseal ostomy seal in North America
UHS to acquire Talkspace for USD835m
Abbott announces quarterly dividend
Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit
Alvotech reports positive PK study results for AVT80 biosimilar candidate
Inspiration Healthcare secures US purchasing agreement to drive Airon growth